AWC
KNSA icon

Abundance Wealth Counselors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Abundance Wealth Counselors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
+4,578
New +$237K 0.02% 233
2021
Q2 		– Sell
-1,000
Closed -$19K – 217
2021
Q1 		$19K Buy
+1,000
New +$20.5K ﹤0.01% 233

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Abundance Wealth Counselors's KNSA Position: Q2 2026 in Review

Abundance Wealth Counselors opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 4,578 shares worth $293K. The stake represents 0.02% of the portfolio and ranks #233 among its holdings. This is a return to the name: Abundance Wealth Counselors previously reported a position in KNSA as recently as Q1 2021.

Abundance Wealth Counselors first reported a position in KNSA in Q1 2021 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Abundance Wealth Counselors held 4,578 shares of Kiniksa Pharmaceuticals worth $293K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Abundance Wealth Counselors position in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.02% of Abundance Wealth Counselors's portfolio in Q2 2026, its #233 holding.
  • Abundance Wealth Counselors first reported a position in Kiniksa Pharmaceuticals in Q1 2021 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.